News and Events

Eurofins Viracor BioPharma is proud to announce that we will be opening a state-of-the art, 110,000 sq. ft testing facility, nearly doubling our footprint in 2022.

27 Sep- 1 Oct 2021

Eurofins will be attending the 15th WRIB and excited to share how our specialized expertise in complex bioassay design, optimization, validation and transfer, customized to your study’s needs — together with testing performed in our high throughput CAP/CLIA laboratory can advance your study design and clinical trial program.

30 Nov- 2 Dec 2021

Eurofins Viracor BioPharma will be exhibiting and sponsoring the World Vaccine and Immunotherapy Congress and we are excited to share our specialized expertise in complex bioassay design, optimization, validation and transfer, customized to your study’s needs.

26-28 Oct 2021

Eurofins Viracor BioPharma will be exhibiting and sponsoring the 6th Annual Oncolytic Virotherapy Summit in Boston, October 26-28th, and we are excited to share our latest comprehensive assay offering for next generation sequencing to enable genomic profiling of tumor samples with PanCancerIQ™.

It was October 2015 when the US immunotherapy market was celebrating its first-ever FDA-approved oncolytic virus therapy, talimogene laherparepve (T-VEC). Developed by Amgen, this new genre of immunotherapy demonstrated immense efficacy in treating advanced melanoma.

Check out the latest BioPharma Newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

May 12-16

Learn something new at Bio-Rad's Exhibitor Showcase featuring Dr. Mark Wissel, Director of R & D at Viracor Eurofins BioPharma Services. Mark will be speaking about Implementing Droplet Digital PCR in a Clinical Trial Testing on May 12, 2021 at 11:35 AM EST.

Check out the latest Eurofins Viracor BioPharma Press Releases:

Check out the latest BioPharma Newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

Dec 1-3

RT-qPCR and Sequencing Testing Supporting SARS-CoV-2 Vaccine Clinical Trials

Presented By Mark Wissel